Related Experiment Videos

Monitoring clinical trials with multiple arms

M Hellmich1

  • 1Department of Medical Statistics, Informatics and Epidemiology, University of Cologne, Germany. martin.hellmich@medizin.uni-koeln.de

Biometrics
|September 12, 2001
PubMed

Insights

Group sequential clinical trials with multiple treatments can drop inferior arms early. This study compares methods, focusing on adaptive closed testing procedures to control error rates in these adaptive trials.

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Medical Research Design

Background:

  • Group sequential clinical trials with multiple arms are increasingly common to manage overhead costs.
  • Early identification and removal of inferior treatment arms are crucial for ethical and economic reasons.
  • Existing methods for monitoring and analyzing such trials require comparison and discussion.

Purpose of the Study:

  • To compare and discuss recently proposed methods for monitoring and analyzing group sequential clinical trials with multiple treatment arms.
  • To focus on the application and extension of adaptive closed testing procedures within the group sequential framework.
  • To ensure strong control of the familywise error rate in multi-arm group sequential trials.

Main Methods:

  • Comparison of recently developed methods for group sequential clinical trials with multiple treatment arms.
  • Application and extension of adaptive closed testing procedures.
  • Utilizing procedures that strongly control the familywise error rate (FWER).

Main Results:

  • Adaptive closed testing procedures offer a robust framework for multi-arm group sequential trials.
  • These procedures effectively control the familywise error rate, even with early stopping of inferior arms.
  • The study provides a numerical example illustrating the practical application of these methods.

Conclusions:

  • Adaptive closed testing procedures are well-suited for multi-arm group sequential trials, allowing for early termination of ineffective treatments.
  • These methods maintain statistical integrity by controlling the familywise error rate.
  • The findings support the use of adaptive designs in clinical trials for efficiency and ethical considerations.

Related Concept Videos